Behavioral profile of P2X7 receptor knockout mice in animal models of depression and anxiety: Relevance for neuropsychiatric disorders

Behavioural Brain Research

Volumn 198, Issue 1, 2009, Pages 83-90

  Basso, Ana M ^a   Bratcher, Natalie A ^a   Harris, Richard R ^a   Jarvis, Michael F ^a   Decker, Michael W ^a   Rueter, Lynne E ^a  

^a ABBOTT LABORATORIES   (United States)

Author keywords

Anxiety; Depression; P2X7 receptor; P2X7 receptor KO mice; Pro inflammatory cytokines

Indexed keywords

IMIPRAMINE; INTERLEUKIN 1; PURINERGIC P2X7 RECEPTOR; INTERLEUKIN 1BETA; PURINERGIC P2 RECEPTOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY DISORDER; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DEPRESSION; DIET RESTRICTION; FOOD INTAKE; FORCED SWIMMING TEST; GENOTYPE; KNOCKOUT MOUSE; LOCOMOTION; MALE; MAZE TEST; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN SECRETION; ANALYSIS OF VARIANCE; ANIMAL; ANIMAL BEHAVIOR; ANXIETY; C57BL MOUSE; DISEASE MODEL; DRUG EFFECT; EATING; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPLORATORY BEHAVIOR; GENETICS; IMMOBILIZATION; IMMUNOLOGY; MOTOR ACTIVITY; MOUSE MUTANT; PATHOPHYSIOLOGY; PHYSIOLOGY; POLYMERASE CHAIN REACTION; SWIMMING;

ANALYSIS OF VARIANCE; ANIMALS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; ANXIETY; BEHAVIOR, ANIMAL; DEPRESSION; DISEASE MODELS, ANIMAL; EATING; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXPLORATORY BEHAVIOR; HINDLIMB SUSPENSION; IMIPRAMINE; INTERLEUKIN-1BETA; MALE; MAZE LEARNING; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOTOR ACTIVITY; POLYMERASE CHAIN REACTION; RECEPTORS, PURINERGIC P2; SWIMMING;

EID: 58549092549     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2008.10.018     Document Type: Article

References (68)

1. Abbracchio M.P., and Burnstock G. Purinergic signalling: pathophysiological roles. Jpn J Pharmacol 78 (1998) 113-145
2. Abkevich V., Camp N.J., Hensel C.H., Neff C.D., Russell D.L., Hughes D.C., et al. Predisposition locus for major depression at chromosome 12q22-12q232. Am J Hum Genet 73 (2003) 1271-1281
3. Anderson C.M., and Nedergaard M. Emerging challenges of assigning P2X7 receptor function and immunoreactivity in neurons. Trends Neurosci 29 (2006) 257-262
4. Anisman H., and Merali Z. Anhedonic and anxiogenic effects of cytokine exposure. Adv Exp Med Biol 461 (1999) 199-233
5. Anisman H., and Merali Z. Cytokines, stress and depressive illness: brain-immune interactions. Ann Med 35 (2003) 2-11
6. Anisman H., and Merali Z. Cytokines, stress, and depressive illness. Brain Behav Immun 16 (2002) 513-524
7. Anisman H., Merali Z., Poulter M.O., and Hayley S. Cytokines as a precipitant of depressive illness: animal and human studies. Curr Pharm Des 11 (2005) 963-972
8. Barden N., Harvey M., Gagne B., Shink E., Tremblay M., Raymond C., et al. Analysis of single nucleotide polymorphisms in genes in the chromosome 12Q24 31 region points to P2RX7 as a susceptibility gene to bipolar affective disorder. Am J Med Genet B Neuropsychiatr Genet 141B (2006) 374-382
9. Bodnoff S.R., Suranyi-Cadotte B., Aitken D.H., Quirion R., and Meaney M.J. The effects of chronic antidepressant treatment in an animal model of anxiety. Psychopharmacology (Berl) 95 (1988) 298-302
10. Brustolim D., Ribeiro-dos-Santos R., Kast R.E., Altschuler E.L., and Soares M.B. A new chapter opens in anti-inflammatory treatments: the antidepressant bupropion lowers production of tumor necrosis factor-alpha and interferon-gamma in mice. Int Immunopharmacol 6 (2006) 903-907
11. Chessell I.P., Hatcher J.P., Bountra C., Michel A.D., Hughes J.P., Green P., et al. Disruption of the P2X7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain. Pain 114 (2005) 386-396
12. Crawley J.N. Exploratory behavior models of anxiety in mice. Neurosci Biobehav Rev 9 (1985) 37-44
13. Cryan J.F., Mombereau C., and Vassout A. The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice. Neurosci Biobehav Rev 29 (2005) 571-625
14. Curtis D., Kalsi G., Brynjolfsson J., McInnis M., O'Neill J., Smyth C., et al. Genome scan of pedigrees multiply affected with bipolar disorder provides further support for the presence of a susceptibility locus on chromosome 12q23-q24, and suggests the presence of additional loci on 1p and 1q. Psychiatr Genet 13 (2003) 77-84
15. D'Aquila P.S., Brain P., and Willner P. Effects of chronic mild stress on performance in behavioural tests relevant to anxiety and depression. Physiol Behav 56 (1994) 861-867
16. Dantzer R. Cytokine-induced sickness behavior: mechanisms and implications. Ann N Y Acad Sci 933 (2001) 222-234
17. Dantzer R., Wollman E., Vitkovic L., and Yirmiya R. Cytokines and depression: fortuitous or causative association?. Mol Psychiatry 4 (1999) 328-332
18. Deuchars S.A., Atkinson L., Brooke R.E., Musa H., Milligan C.J., Batten T.F., et al. Neuronal P2X7 receptors are targeted to presynaptic terminals in the central and peripheral nervous systems. J Neurosci 21 (2001) 7143-7152
19. Dredge K., Connor T.J., Kelly J.P., and Leonard B.E. Differential effect of a single high dose of the tricyclic antidepressant imipramine on interleukin-1beta and tumor necrosis factor-alpha secretion following an in vivo lipopolysaccharide challenge in rats. Int J Immunopharmacol 21 (1999) 663-673
20. Dunn A.J., Wang J., and Ando T. Effects of cytokines on cerebral neurotransmission. Comparison with the effects of stress. Adv Exp Med Biol 461 (1999) 117-127
21. Fernandez Espejo E. Structure of the mouse behaviour on the elevated plus-maze test of anxiety. Behav Brain Res 86 (1997) 105-112
22. Ferrari D., Pizzirani C., Adinolfi E., Lemoli R.M., Curti A., Idzko M., et al. The P2X7 receptor: a key player in IL-1 processing and release. J Immunol 176 (2006) 3877-3883
23. Greig A.V., Linge C., Cambrey A., and Burnstock G. Purinergic receptors are part of a signaling system for keratinocyte proliferation, differentiation, and apoptosis in human fetal epidermis. J Invest Dermatol 121 (2003) 1145-1149
24. Griffiths R.J., Stam E.J., Downs J.T., and Otterness I.G. ATP induces the release of IL-1 from LPS-primed cells in vivo. J Immunol 154 (1995) 2821-2828
25. Guerra A.N., Fisette P.L., Pfeiffer Z.A., Quinchia-Rios B.H., Prabhu U., Aga M., et al. Purinergic receptor regulation of LPS-induced signaling and pathophysiology. J Endotoxin Res 9 (2003) 256-263
26. Hayley S., Poulter M.O., Merali Z., and Anisman H. The pathogenesis of clinical depression: stressor- and cytokine-induced alterations of neuroplasticity. Neuroscience 135 (2005) 659-678
27. Heisler L.K., Chu H.M., Brennan T.J., Danao J.A., Bajwa P., Parsons L.H., et al. Elevated anxiety and antidepressant-like responses in serotonin 5-HT1A receptor mutant mice. Proc Natl Acad Sci U S A 95 (1998) 15049-15054
28. Hestad K.A., Tonseth S., Stoen C.D., Ueland T., and Aukrust P. Raised plasma levels of tumor necrosis factor alpha in patients with depression: normalization during electroconvulsive therapy. J Ect 19 (2003) 183-188
29. Hide I., Tanaka M., Inoue A., Nakajima K., Kohsaka S., Inoue K., et al. Extracellular ATP triggers tumor necrosis factor-alpha release from rat microglia. J Neurochem 75 (2000) 965-972
30. Kraus M.R., Schafer A., Faller H., Csef H., and Scheurlen M. Paroxetine for the treatment of interferon-alpha-induced depression in chronic hepatitis C. Aliment Pharmacol Ther 16 (2002) 1091-1099
31. Labasi J.M., Petrushova N., Donovan C., McCurdy S., Lira P., Payette M.M., et al. Absence of the P2X7 receptor alters leukocyte function and attenuates an inflammatory response. J Immunol 168 (2002) 6436-6445
32. Lanquillon S., Krieg J.C., Bening-Abu-Shach U., and Vedder H. Cytokine production and treatment response in major depressive disorder. Neuropsychopharmacology 22 (2000) 370-379
33. Larson S.J., and Dunn A.J. Behavioral effects of cytokines. Brain Behav Immun 15 (2001) 371-387
34. Levine J., Barak Y., Chengappa K.N., Rapoport A., Rebey M., and Barak V. Cerebrospinal cytokine levels in patients with acute depression. Neuropsychobiology 40 (1999) 171-176
35. Licinio J., and Wong M.L. The role of inflammatory mediators in the biology of major depression: central nervous system cytokines modulate the biological substrate of depressive symptoms, regulate stress-responsive systems, and contribute to neurotoxicity and neuroprotection. Mol Psychiatry 4 (1999) 317-327
36. Lin A., Song C., Kenis G., Bosmans E., De Jongh R., Scharpe S., et al. The in vitro immunosuppressive effects of moclobemide in healthy volunteers. J Affect Disord 58 (2000) 69-74
37. Lister R.G. The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology (Berl) 92 (1987) 180-185
38. Lucae S., Salyakina D., Barden N., Harvey M., Gagne B., Labbe M., et al. P2RX7, a gene coding for a purinergic ligand-gated ion channel, is associated with major depressive disorder. Hum Mol Genet 15 (2006) 2438-2445
39. MacKenzie A., Wilson H.L., Kiss-Toth E., Dower S.K., North R.A., and Surprenant A. Rapid secretion of interleukin-1beta by microvesicle shedding. Immunity 15 (2001) 825-835
40. Maes M. Evidence for an immune response in major depression: a review and hypothesis. Prog Neuropsychopharmacol Biol Psychiatry 19 (1995) 11-38
41. Maes M. The immunoregulatory effects of antidepressants. Hum Psychopharmacol 16 (2001) 95-103
42. Maes M. Major depression and activation of the inflammatory response system. Adv Exp Med Biol 461 (1999) 25-46
43. Merali Z., Brennan K., Brau P., and Anisman H. Dissociating anorexia and anhedonia elicited by interleukin-1beta: antidepressant and gender effects on responding for "free chow" and "earned" sucrose intake. Psychopharmacology (Berl) 165 (2003) 413-418
44. Mineur Y.S., Belzung C., and Crusio W.E. Effects of unpredictable chronic mild stress on anxiety and depression-like behavior in mice. Behav Brain Res 175 (2006) 43-50
45. Mombereau C., Kaupmann K., van der Putten H., and Cryan J.F. Altered response to benzodiazepine anxiolytics in mice lacking GABA B(1) receptors. Eur J Pharmacol 497 (2004) 119-120
46. Neary J.T., Rathbone M.P., Cattabeni F., Abbracchio M.P., and Burnstock G. Trophic actions of extracellular nucleotides and nucleosides on glial and neuronal cells. Trends Neurosci 19 (1996) 13-18
47. North R.A. Molecular physiology of P2X receptors. Physiol Rev 82 (2002) 1013-1067
48. Parks C.L., Robinson P.S., Sibille E., Shenk T., and Toth M. Increased anxiety of mice lacking the serotonin1A receptor. Proc Natl Acad Sci U S A 95 (1998) 10734-10739
49. Penninx B.W., Kritchevsky S.B., Yaffe K., Newman A.B., Simonsick E.M., Rubin S., et al. Inflammatory markers and depressed mood in older persons: results from the Health Aging and Body Composition study. Biol Psychiatry 54 (2003) 566-572
50. Petit-Demouliere B., Chenu F., and Bourin M. Forced swimming test in mice: a review of antidepressant activity. Psychopharmacology (Berl) 177 (2005) 245-255
51. Pollak Y., and Yirmiya R. Cytokine-induced changes in mood and behaviour: implications for 'depression due to a general medical condition', immunotherapy and antidepressive treatment. Int J Neuropsychopharmacol 5 (2002) 389-399
52. Porsolt R.D., Bertin A., and Jalfre M. Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther 229 (1977) 327-336
53. Ramboz S., Oosting R., Amara D.A., Kung H.F., Blier P., Mendelsohn M., et al. Serotonin receptor 1A knockout: an animal model of anxiety-related disorder. Proc Natl Acad Sci U S A 95 (1998) 14476-14481
54. Rodgers R.J. Animal models of 'anxiety': where next?. Behav Pharmacol 8 (1997) 497-504 477-496 [discussion]
55. Rossler A.S., Joubert C., and Chapouthier G. Chronic mild stress alleviates anxious behaviour in female mice in two situations. Behav Processes 49 (2000) 163-165
56. Shink E., Harvey M., Tremblay M., Gagne B., Belleau P., Raymond C., et al. Analysis of microsatellite markers and single nucleotide polymorphisms in candidate genes for susceptibility to bipolar affective disorder in the chromosome 12Q24 31 region. Am J Med Genet B Neuropsychiatr Genet 135B (2005) 50-58
57. Shink E., Morissette J., Sherrington R., and Barden N. A genome-wide scan points to a susceptibility locus for bipolar disorder on chromosome 12. Mol Psychiatry 10 (2005) 545-552
58. Smith R.S. The macrophage theory of depression. Med Hypotheses 35 (1991) 298-306
59. Solle M., Labasi J., Perregaux D.G., Stam E., Petrushova N., Koller B.H., et al. Altered cytokine production in mice lacking P2X(7) receptors. J Biol Chem 276 (2001) 125-132
60. Sperlagh B., Kofalvi A., Deuchars J., Atkinson L., Milligan C.J., Buckley N.J., et al. Involvement of P2X7 receptors in the regulation of neurotransmitter release in the rat hippocampus. J Neurochem 81 (2002) 1196-1211
61. Steru L., Chermat R., Thierry B., Mico J.A., Lenegre A., Steru M., et al. The automated Tail Suspension Test: a computerized device which differentiates psychotropic drugs. Prog Neuropsychopharmacol Biol Psychiatry 11 (1987) 659-671
62. Stork O., Ji F.Y., Kaneko K., Stork S., Yoshinobu Y., Moriya T., et al. Postnatal development of a GABA deficit and disturbance of neural functions in mice lacking GAD65. Brain Res 865 (2000) 45-58
63. Swiergiel A.H., and Dunn A.J. Distinct roles for cyclooxygenases 1 and 2 in interleukin-1-induced behavioral changes. J Pharmacol Exp Ther 302 (2002) 1031-1036
64. Tuglu C., Kara S.H., Caliyurt O., Vardar E., and Abay E. Increased serum tumor necrosis factor-alpha levels and treatment response in major depressive disorder. Psychopharmacology (Berl) 170 (2003) 429-433
65. Wattler S., Kelly M., and Nehls M. Construction of gene targeting vectors from lambda KOS genomic libraries. Biotechniques 26 (1999) 1150-1156 1158, 1160
66. Wichers M., and Maes M. The psychoneuroimmuno-pathophysiology of cytokine-induced depression in humans. Int J Neuropsychopharmacol 5 (2002) 375-388
67. Xia Z., DePierre J.W., and Nassberger L. Tricyclic antidepressants inhibit IL-6 IL-1 beta and TNF-alpha release in human blood monocytes and IL-2 and interferon-gamma in T cells. Immunopharmacology 34 (1996) 27-37
68. Yirmiya R., Pollak Y., Barak O., Avitsur R., Ovadia H., Bette M., et al. Effects of antidepressant drugs on the behavioral and physiological responses to lipopolysaccharide (LPS) in rodents. Neuropsychopharmacology 24 (2001) 531-544